Cresco Labs enters Florida market by acquiring assets of VidaCann Ltd.
Category: #business  By Mateen Dalal  Date: 2019-03-19
  • share
  • Twitter
  • Facebook
  • LinkedIn

Cresco Labs enters Florida market by acquiring assets of VidaCann Ltd.

The purchase consideration is approx. $120m and would consist of a mixture of cash and Cresco Labs shares

Cresco would be having 21 retail dispensaries and 14 production facilities upon the closing of the transaction

U.S. based leading vertically integrated multistate cannabis operator, Cresco Labs Inc., has recently announced that the company is entering the Florida market. Apparently, this would be executed via signing of a letter agreement for acquiring the assets or ownership interests of VidaCann Ltd., one of the most advanced and largest providers of medical cannabis in Florida, and/ or its affiliated entities.

Sources familiar with the matter informed that the purchase consideration is approx. $120 million and would be consisting of a mixture of cash and Cresco Labs shares, that would be subjected to a 6 to 12 month of lock-up agreement followed by closing. This stock and proportion of cash and final purchase price would be determined and reflected in the definitive agreement.

Reportedly, Cresco Labs would have 21 retail dispensaries and 14 production facilities upon the closing of the transaction, besides having licenses for operating a sum of 51 retail dispensaries across 10 states, such as Florida, Arizona, California, Nevada, Ohio, Pennsylvania, Illinois with Massachusetts, Maryland and New York pending approval.

Charlie Bachtell, Co-founder and Chief Executive of Cresco Labs, mentioned that entering the Florida market is in line with the strategy of the company of entering markets with strong regulatory structures with outsized demand. It is a crucial milestone for Cresco Labs that largely impacts the company’s growth trajectory and would be accretive to its earnings in 2019, he said.

Bachtell added that Florida has witnessed remarkable growth in patient registration since relaunching its cannabis program in 2017 and is among the most significant markets in the nation. The company looks forward towards welcoming all of the 100 VidaCann employees to the family of Cresco Labs.

For the record, Bennett Jones is acting as the Canadian legal advisor, and Canaccord Genuity Corp. as the financial advisor to Cresco Labs.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

AstraZenecas Farxiga gets fast track status to treat heart failure
AstraZenecas Farxiga gets fast track status to treat heart failure
By Mateen Dalal

With heart related issues and number of people diagnosed with heart failure increasing substantially, the need to find a solution to this problem is growing considerably. Advanced technology, equipment and pharmaceutical companies are continuously wo...

Upstream Works, Aceyus to pioneer customer experience solutions
Upstream Works, Aceyus to pioneer customer experience solutions
By Mateen Dalal

Customer Experience (CX) is vital for companies to understand the mindset of their clients. Industries are actively investing in customer experience solutions to stay ahead in competition. Companies are also partnering with other market players to en...

Patient data from Oncopeptides’ Phase 2 trial to be showcased at IMW
Patient data from Oncopeptides’ Phase 2 trial to be showcased at IMW
By Mateen Dalal

Patients having Relapsed-refractory multiple myeloma (RRMM) along with extramedullary disease (EMD) will be treated by Oncopeptides AB. In the company’s HORIZON trial, a cumulative response rate of 23% was attained with dexamethasone and mel...